Review
doi: 10.1002/lt.20618.
Kidney dysfunction in the recipients of liver transplants
Affiliations
- PMID: 16237714
- DOI: 10.1002/lt.20618
Item in Clipboard
Review
Kidney dysfunction in the recipients of liver transplants
Liver Transpl.
2005 Nov.
Free article
Abstract
1. Pretransplant kidney function is an important predictor of posttransplant kidney function. 2. Chronic kidney disease is present in 20% of liver transplant recipients by 5 years. 3. Kidney function is impacted by pretransplant management of the consequences of the hepatorenal syndrome. 4. The use of calcineurin inhibitor (CNI)-based immunosuppression is an important factor in the development of chronic kidney disease, and the use of mycophenolic acid- or sirolimus-based immunosuppression with reduced-dose CNI may be of benefit.
Similar articles
-
A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function.Liver Transpl. 2007 Dec;13(12):1694-702. doi: 10.1002/lt.21314. Liver Transpl. 2007. PMID: 18044728 Clinical Trial.
-
Sirolimus in cardiac transplantation: use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity.J Heart Lung Transplant. 2005 Dec;24(12):2129-36. doi: 10.1016/j.healun.2005.08.015. J Heart Lung Transplant. 2005. PMID: 16364861 Clinical Trial.
-
Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients.Transplantation. 2007 Aug 27;84(4):467-74. doi: 10.1097/01.tp.0000276959.56959.69. Transplantation. 2007. PMID: 17713429 Clinical Trial.
-
Calcineurin nephrotoxicity.Adv Chronic Kidney Dis. 2006 Jan;13(1):47-55. doi: 10.1053/j.ackd.2005.11.001. Adv Chronic Kidney Dis. 2006. PMID: 16412970 Review.
-
Chronic allograft dysfunction: can we use mammalian target of rapamycin inhibitors to replace calcineurin inhibitors to preserve graft function?Curr Opin Organ Transplant. 2008 Dec;13(6):614-21. doi: 10.1097/MOT.0b013e3283193bad. Curr Opin Organ Transplant. 2008. PMID: 19060552 Review.
Cited by
-
Sustained renal response to mycophenolate mofetil and CNI taper promotes survival in liver transplant patients with CNI-related renal dysfunction.Dig Dis Sci. 2011 Jan;56(1):244-51. doi: 10.1007/s10620-010-1386-z. Epub 2010 Sep 8. Dig Dis Sci. 2011. PMID: 20824504
-
Evidence for the immunosuppressive potential of calcineurin inhibitor-sparing regimens in liver transplant recipients with impaired renal function.J Transplant. 2011;2011:483728. doi: 10.1155/2011/483728. Epub 2011 Jul 6. J Transplant. 2011. PMID: 21785695 Free PMC article.
-
Acute kidney injury and post-reperfusion syndrome in liver transplantation.World J Gastroenterol. 2016 Nov 14;22(42):9314-9323. doi: 10.3748/wjg.v22.i42.9314. World J Gastroenterol. 2016. PMID: 27895419 Free PMC article. Review.
-
Sequential Cohort Analysis After Liver Transplantation Shows de Novo Extended Release Tacrolimus Is Safe, Efficacious, and Minimizes Renal Dysfunction.Transplant Direct. 2020 Jan 17;6(2):e528. doi: 10.1097/TXD.0000000000000970. eCollection 2020 Feb. Transplant Direct. 2020. PMID: 32095514 Free PMC article.
-
Pre-transplant kidney function predicts chronic kidney disease after liver transplant: meta-analysis of observational studies.Dig Dis Sci. 2011 May;56(5):1282-9. doi: 10.1007/s10620-010-1529-2. Epub 2011 Jan 8. Dig Dis Sci. 2011. PMID: 21221799
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
